57 related articles for article (PubMed ID: 34969829)
1. The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma.
Swift BE; Covens A; Mintsopoulos V; Parra-Herran C; Bernardini MQ; Nofech-Mozes S; Hogen L
Int J Gynecol Cancer; 2022 Apr; 32(4):525-531. PubMed ID: 34969829
[TBL] [Abstract][Full Text] [Related]
2. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
[TBL] [Abstract][Full Text] [Related]
3. Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary.
Mazina V; Devins K; Philp L; Bercow AS; James K; Bregar A; Sisodia RC; Oliva E; Del Carmen M
Int J Gynecol Cancer; 2023 Sep; 33(9):1434-1439. PubMed ID: 37567599
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic
Kurnit KC; Fellman BM; Mills GB; Bowser JL; Xie S; Broaddus RR
Int J Gynecol Cancer; 2022 Jul; 32(7):869-874. PubMed ID: 35483739
[TBL] [Abstract][Full Text] [Related]
5. Effects of radiotherapy on the survival of patients with stage IA and low-grade stage IB uterine endometrioid carcinoma.
Li S; Yi Z; Li M; Zhu Z
Sci Rep; 2023 Nov; 13(1):19883. PubMed ID: 37963944
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic comparison of active surveillance and adjuvant chemotherapy in the treatment of patients with stage Ⅰ ovarian immature teratoma after fertility-sparing surgery].
Zhang XY; Yang J; Xiang Y; Wu M; Pan LY; Yang JX
Zhonghua Fu Chan Ke Za Zhi; 2023 Nov; 58(11):838-845. PubMed ID: 37981770
[No Abstract] [Full Text] [Related]
8. Is There Re-staging Surgery Necessity for Borderline Ovarian Tumors.
Guo LL; Kang XY; Su Y; Liu XY; Wu X; Xie W; Liu YH; Wang CY
Curr Med Sci; 2023 Aug; 43(4):822-830. PubMed ID: 37455277
[TBL] [Abstract][Full Text] [Related]
9. Low-grade endometrioid endometrial cancer with adnexal only metastasis: Evaluation of de-escalation of adjuvant therapy.
Matsuo K; Chen L; Neuman MK; Klar M; Roman LD; Wright JD
Eur J Cancer; 2024 Mar; 200():113533. PubMed ID: 38309016
[TBL] [Abstract][Full Text] [Related]
10. Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study.
Chan JK; Tian C; Kesterson JP; Lin KY; Darcy K; Richardson MT; Kapp DS; Monk BJ; McNally L; Landrum L; Copeland L; Walker JL; Wenham RM; Phippen N; Spirtos NM; Tewari K; Shahin M; Berry L; Bell JG
Gynecol Oncol; 2024 Feb; 181():54-59. PubMed ID: 38134754
[TBL] [Abstract][Full Text] [Related]
11. Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A retrospective observational study.
Shah A; Apple J; Belli AJ; Barcellos A; Hansen E; Fernandes LL; Zettler CM; Wang CK
Cancer Treat Res Commun; 2023; 36():100742. PubMed ID: 37478531
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer.
Liu Z; Lang J; Wu M; Li L
Front Oncol; 2020; 10():618499. PubMed ID: 33665168
[TBL] [Abstract][Full Text] [Related]
13. Recurrence risk factors in stage IA grade 1 endometrial cancer.
Nwachukwu C; Baskovic M; Von Eyben R; Fujimoto D; Giaretta S; English D; Kidd E
J Gynecol Oncol; 2021 Mar; 32(2):e22. PubMed ID: 33470064
[TBL] [Abstract][Full Text] [Related]
14. Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer.
Swift BE; Covens A; Mintsopoulos V; Parra-Herran C; Bernardini MQ; Nofech-Mozes S; Hogen L
Int J Gynecol Cancer; 2022 Jun; ():. PubMed ID: 35768155
[TBL] [Abstract][Full Text] [Related]
15. A qualitative systematic review of the significance of adjuvant therapy in patients with low-risk endometrial cancer presenting positive peritoneal cytology: a relevant study to the guideline update for endometrial cancer by the Japan society of gynecologic oncology guideline committee.
Shigeta S; Konno Y; Terai Y; Morisada T; Tokunaga H; Baba T; Kobayashi Y; Nagase S
Jpn J Clin Oncol; 2024 Feb; 54(2):217-220. PubMed ID: 37823222
[TBL] [Abstract][Full Text] [Related]
16. Clinical calculator redefines prognosis for high-risk early-stage ovarian cancers and potential to guide treatment in the adjuvant setting.
Bui A; Gehrig PA; Ghamande S; Rungruang BJ; Chan JK; Mysona DP
Gynecol Oncol; 2022 Nov; 167(2):205-212. PubMed ID: 36055814
[TBL] [Abstract][Full Text] [Related]
17. Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Multicentric Turkish study.
Erdogan O; Kilic C; Cakir C; Kilic F; Oktar O; Ersak B; Sahin M; Tokalioglu A; Kocak O; Ozturk C; Gorgulu G; Gokkaya M; Selcuk I; Korkmaz V; Comert GK; Toptas T; Ureyen I; Ucar G; Taskin S; Tasci T; Uncu D; Narin MA; Boran N; Ozdal B; Tekin OM; Ustun Y; Sancı M; Ortac F; Turan T
Asia Pac J Clin Oncol; 2024 Feb; 20(1):46-54. PubMed ID: 37096294
[TBL] [Abstract][Full Text] [Related]
18. Can adjuvant chemotherapy improve the prognosis of adult ovarian granulosa cell tumors?: A narrative review.
Zhuang Y; Zhang S; Liu Y; Yang H
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356927
[TBL] [Abstract][Full Text] [Related]
19. Quantification of recurrence risk based on number of adverse prognostic factors in women with stage I uterine endometrioid carcinoma.
Cook AE; Aref I; Burmeister C; Hijaz M; Elshaikh MA
J Turk Ger Gynecol Assoc; 2021 Dec; 22(4):262-267. PubMed ID: 34866366
[TBL] [Abstract][Full Text] [Related]
20. Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy.
Marino G; Grassi T; De Ponti E; Negri S; Testa F; Giuliani D; Delle Marchette M; Dell'Oro C; Fumagalli D; Donatiello G; Besana G; Marchetta L; Bonazzi CM; Lissoni AA; Landoni F; Fruscio R
Front Oncol; 2024; 14():1330481. PubMed ID: 38371620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
